Navigation Links
Anonymization remains a powerful approach to protecting the privacy of health information

OTTAWA, ON December 8, 2011 De-identification of health data has been crucial for all types of health research, but recent articles in medical and scientific literature have suggested that de-identification methods do not sufficiently protect the identities of individuals and can be easily reversed. A recent review conducted by researchers at CHEO entitled "A Systematic Review of Re-identification Attacks on Health Data" and published in PLoS ONE, did not uncover evidence to support this. "If re-identification rates were as high as some of these articles suggest, it would be worrisome," says lead author, Dr. Khaled El-Emam. "But our review did not support these claims there is no broad empirical support for a failure of anonymization."

Such a failure would have significant policy implications. For example, it may become necessary to obtain patient consent before data is released (a time-consuming undertaking), incentive to de-identify would decline, and the likelihood of breaches would increase. For this reason, Dr. El-Emam and his team conducted a review that set out to characterize known re-identification attacks on health data and compare them to attacks on other types of data, calculate the number of records correctly identified in these attacks, and assess whether the results indicate a weakness in current de-identification methods.

After identifying 14 relevant studies and analyzing them in detail, the group was unable to find convincing evidence that existing de-identification methods are not effective. Few of these attacks involved health data which is naturally protected more strenuously. Secondly, many of the attacks were on small databases with large confidence intervals around their success rates. Most importantly, the majority of re-identified data was not de-identified according to existing standards. "Of the 24 studies we examined, only six were attacks on health data and only one of these was de-identified according to standards," Dr. El-Emam points out. "In that particular study, the proportion of correctly re-identified records was very low: about 0.013%."

In certain well-publicized re-identification attacks, adversaries were able to make use of such information as an individual's date of birth, gender, and residential zip code. Since these 3 features were not modified in any way, the database would not meet basic standards for de-identification. If anything, such a breach serves to underscore the importance of implementing existing de-identification standards.

Dr. El-Emam concludes by saying that in order to have a more accurate picture of the extent to which de-identification protects against real attacks, future research on re-identification attacks should focus on large databases that have been de-identified according to existing standards, and that success rates should be correlated with how well de-identification was performed. In the meantime, it is suggested that data custodians continue to de-identify using current best practices.


Contact: Adrienne Vienneau
613-737-7600 x4144
Children's Hospital of Eastern Ontario Research Institute

Related medicine news :

1. A Healthy Diet Remains Your Best Weapon Against the #1 Killer: Heart Disease
2. JDR increases its 5-Year SIF and remains number one dental journal of 64 in its category
3. Green And Greener Survey Shows Hospitals Embrace Environmentally Sustainable Practices, Though Room for Improvement Remains
4. Lack of insurance coverage remains obstacle to wider colorectal cancer screening with CT colonography
5. Surgery or stenting for carotid artery disease? Question remains
6. Results of the placement of multiple endoscopic stents for postoperative biliary strictures remains excellent after long-term follow-up
7. Adults in Puerto Rico aware of genetic testing, but use remains low
8. Religious Identity Remains Constant in Teen Years: Study
9. Benefit of blood glucose lowering to near-normal levels remains unclear
10. Evidence in the field of CVD in pregnancy is sparse, but the condition remains a concern:
11. New report: US investment in health research remains stagnant
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... “While riding the bus, I ... Bronx, N.Y. “I thought there had to be a convenient and comfortable way to ... The PROTECTOR enables disabled individuals to safely travel during cold or inclement weather. In ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care ... disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... philanthropic seniors, is resulting in a way for homeless people to have a ... have launched a new initiative whereby they are repurposing plastic bags into sleeping ...
(Date:11/25/2015)... ... November 25, 2015 , ... Since its launch in 2012, ... adult stem cell therapies to patients with chronic degenerative medical conditions. Now, the ... Registered Trademark (RTM). , Organizations are required to hold a registered trademark in ...
(Date:11/24/2015)... ... November 25, 2015 , ... Genesis Chiropractic Software ... software creates an agreement between the practice owner and the patient that automatically ... notification, and projections. Click here to learn more. , ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... FRANCISCO , Nov. 24, 2015  Thanks to ... Dignity Health St. Mary,s Medical Center,s Sister Diane Grassilli ... breast imaging capabilities in San Francisco ... an anonymous friend, stepped forward with a gift of ... for Breast Digital Mammography with Tomosynthesis and Whole Breast ...
(Date:11/24/2015)... Colo. , Nov. 24, 2015  Array ... that its Chief Executive Officer, Ron Squarer ... Healthcare Conference in New York.  The public is ... webcast on the Array BioPharma website.Event:Piper Jaffray Annual ... , Wednesday, December 2, 2015Time:1:30 p.m. Eastern Time ...
(Date:11/24/2015)... HOUSTON, TX and VANCOUVER, Nov. 24, 2015 /PRNewswire/ ... EPI; NASDAQ: EPIX ) announced today that the ... clinical study of EPI-506 as a treatment for metastatic ... States and Canada.  --> ... --> In the Phase 1/2 clinical trial, ...
Breaking Medicine Technology: